Evidence map›Paper›PMID 38800973›Full record

ArticleDrug and alcohol review2025

Co-creating and implementing a novel pre-conference event to promote equity and inclusivity among academic researchers and people who use drugs.

M J Stowe, Louise Hansford, Rachel Halford, Jason Wallace, Lise Lafferty

Abstract read
In one paragraph

Article in Drug and alcohol review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

M J StoweThe Kirby Institute, UNSW Sydney, Sydney, Australia.
Louise HansfordMidlands Partnership Foundation Trust, National Health Service, Stafford, UK.
Rachel HalfordThe Hepatitis C Trust, London, UK.
Jason WallaceScottish Drugs Forum, Glasgow, UK.
Lise LaffertyThe Kirby Institute, UNSW Sydney, Sydney, Australia.ORCID 0000-0002-8533-2957

Funding

Glasgow Caledonian UniversityUniversity of BristolUniversity of New South Wales
6 · The paper itself

Abstract

This commentary draws on our experience organising a targeted networking event at the 10th International Conference on Health and Hepatitis in Substance Users, in Glasgow, Scotland in October 2022. The event, held the day before the conference, brought together people with lived and living experiences of drug use and early- and mid-career researchers on an equitable basis. We offer reflections, focussing on how the event promoted community-academic engagement from members of the respective groups. We provide recommendations for how conferences can organise to engage with people who use drugs-both those with lived and living experience and foster greater inclusion for all attendees.

Indexed as

Congresses as TopicDrug UsersResearch PersonnelSubstance-Related DisordersHumansScotlandconferencesearly‐ and mid‐career researchersinclusivitynetworkingpeople who use drugs

Identifiers

PMID38800973
PMCPMC11743231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.